Home › Funds › Metavasi Capital LP › HIMS

Metavasi Capital LP position in HIMS

HIMS & HERS HEALTH INC · Health Care

Metavasi Capital LP reported holding 546,429 shares of HIMS (HIMS & HERS HEALTH INC) in its Q2 2026 13F filing — a position valued at US$18.9M, representing 7.09% of its reported portfolio and ranking #3 among its reported holdings. Metavasi Capital LP has disclosed HIMS holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)546.43K sh
Reported value held$18.94M
Portfolio Weight7.09%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Metavasi Capital LP's HIMS position evolved

Metavasi Capital LP first disclosed a stake in HIMS in Q2 2024 at 505,000 shares (US$10.2M). The position peaked in Q2 2026 at 546,429 shares, worth US$18.9M. Across 8 filings, Metavasi Capital LP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 546,429 shares valued at US$18.9M — an increase of 324,429 shares quarter over quarter.. Notable position changes include a 57% trim in Q4 2024 (shares rose 22% over the following quarter), a 146% increase in Q2 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 505.00K $10.20M New
Q3 2024 434.42K $8.00M Reduce
Q4 2024 187.42K $4.53M Reduce
Q1 2025 193.97K $5.73M Add
Q2 2025 186.41K $9.29M Reduce
Q3 2025 166.41K $9.44M Reduce
Q1 2026 222.00K $4.61M New
Q2 2026 546.43K $18.94M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HIMS and 13F data

HIMS (HIMS & HERS HEALTH INC) is a Health Care company. 35 other funds we track also report a position in HIMS — the largest reported positions include Divisadero Street Capital Management, LP (US$208.3M), Marex Group Ltd (US$33.8M), Bienville Capital Management, LLC (US$27.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HIMS

All HIMS fund holders →

FAQ

How long has Metavasi Capital LP held HIMS?

Metavasi Capital LP has disclosed HIMS holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

What is Metavasi Capital LP's current position in HIMS?

As of Q2 2026, Metavasi Capital LP holds 546.43K shares of HIMS (HIMS & HERS HEALTH INC), valued at $18.94M, representing 7.09% of its reported portfolio and ranking #3.

Has Metavasi Capital LP been buying or selling HIMS?

In the latest 13F filing (Q2 2026), Metavasi Capital LP increased its position in HIMS. The position peaked in Q2 2026 at 546.43K shares.

Which other funds hold HIMS?

Other major institutional holders of HIMS include Divisadero Street Capital Management, LP, Marex Group Ltd, Bienville Capital Management, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.